NDC 17163-055 - API E.M. Erythromycin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17163-055
- Package NDCs from labels
- 17163-055-16
- Manufacturer
- MARS FISHCARE NORTH AMERICA, INC.
- Effective date
- 2021-12-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Drug Label | MARS FISHCARE NORTH AMERICA, INC. | 2021-12-29 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17163-055-16 | API E.M. Erythromycin | 2 g in 1 PACKET | POWDER | 2 | 7 | |
| 17163-055-16 | API E.M. Erythromycin | 10 in 1 BOX | POWDER | 10 | 7 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ery | ERYTHROMYCIN | Bryant Ranch Prepack | 0742e636-92b2-48bb-bf01-655e32a61461 | 2023-07-17 | Warnings, Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Bryant Ranch Prepack | 939bccc7-b4a0-4a5c-a6f5-b12627ff8e9b | 2023-07-17 | Warnings, Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Zydus Lifesciences Limited | 76608fdd-1248-4942-9518-fd8076244fa7 | 2023-06-21 | 63937KV33D | |
| Erythromycin | ERYTHROMYCIN | Padagis Israel Pharmaceuticals Ltd | dd64459e-c88f-4ca8-b63b-fb96377a3921 | 2023-04-01 | Warnings, Adverse reactions | 63937KV33D |
| erythromycin | ERYTHROMYCIN | A-S Medication Solutions | 1df12239-6957-4b2c-9e65-e2154eafddd0 | 2023-02-04 | Adverse reactions | 63937KV33D |
| erythromycin | ERYTHROMYCIN | Padagis Israel Pharmaceuticals Ltd | 40edf1bd-42bb-4662-aff6-01fcc133c05d | 2022-08-27 | Warnings, Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Proficient Rx LP | 5101bf55-cacf-42bf-8dd1-2a29e80ca6f1 | 2022-07-01 | Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Proficient Rx LP | 62896bec-669e-4f20-a1e4-4f99afd35d32 | 2022-04-01 | Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Asclemed USA, Inc. | bccdb8f3-b5f5-4f07-8ddb-8811d5c1b73c | 2022-03-07 | Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Asclemed USA, Inc. | 7810e881-5130-4a94-b2e0-9f63f8a7a504 | 2021-11-30 | Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Orange Pharmaceuticals USA LLC | 379ed8f7-b54f-495f-932e-cd0e4c691134 | 2021-07-05 | Warnings, Adverse reactions | 63937KV33D |
| ERYTHROMYCIN | ERYTHROMYCIN | Arbor Pharmaceuticals, Inc. | ddd9ad9a-fc60-409a-a2b3-be51482ef751 | 2019-03-19 | Warnings, Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Wilshire Pharmaceuticals | f2efbc94-64f7-4130-ab23-e5983854f730 | 2019-01-14 | Warnings, Adverse reactions | 63937KV33D |
| Erythromycin | ERYTHROMYCIN | Arbor Pharmaceuticals, Inc. | ca1326d6-c5c6-4572-96b6-e56cd944799c | 2018-12-04 | Warnings, Adverse reactions | 63937KV33D |
| ERY-TAB | ERYTHROMYCIN | Arbor Pharmaceuticals, Inc. | fda44eb6-7901-4b80-ba0b-216f6cacf3fd | 2018-12-04 | Warnings, Adverse reactions | 63937KV33D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.